Skip to content
EntityQ3742491· pop 8· linked from 285 articles

Also known as Fentiazaco, Fentiazacum, 4-(p-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid, 4-(4-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid

Fentiazac is a thiazole-based nonsteroidal anti-inflammatory drug (NSAID) developed for use in joint and muscular pain. Like most other NSAIDs, it acts through inhibition of prostaglandin synthesis, via non-selective inhibition of both COX-1 and COX-2. First described in 1974, it was synthesized using the Hantzsch thiazole synthesis.

In the Vinony graph

Vinony's link graph records 285 inbound references to fentiazac, and connects out to salicylic acid, non-steroidal anti-inflammatory drug and metamizole sodium.

It sits within the topics 4-Chlorophenyl compounds, Acetic acids and Chemical pages without DrugBank identifier.

Vinony links it to 7 Wikipedia language editions.

Research

58 papers

via PubMed

Wikidata facts

Mass
329.028
Show 4 more facts
chemical formula
C₁₇H₁₂ClNO₂S
canonical SMILES
C1=CC=C(C=C1)C2=NC(=C(S2)CC(=O)O)C3=CC=C(C=C3)Cl
MCN code
2934.10.10
Commons category
Fentiazac
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

Fentiazac is a thiazole-based nonsteroidal anti-inflammatory drug (NSAID) developed for use in joint and muscular pain. Like most other NSAIDs, it acts through inhibition of prostaglandin synthesis, via non-selective inhibition of both COX-1 and COX-2. First described in 1974, it was synthesized using the Hantzsch thiazole synthesis.

Fentiazac was marketed under the trade-name Norvedan (among others), but its market status is currently unknown and assumed to be discontinued.

Excerpted from Wikipedia’s “fentiazac” article, available under the CC BY-SA 4.0 licence.

Available in 7 languages

via Wikidata sitelinks · CC0

Connections

Categories